{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:19:06Z","timestamp":1787681946555,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jceh.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:13:46Z","timestamp":1615421626000},"page":"646-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children"],"prefix":"10.1016","volume":"11","author":[{"given":"Pawe\u0142","family":"Ma\u0142ecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-2560","authenticated-orcid":false,"given":"Anna","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2182-5699","authenticated-orcid":false,"given":"Magdalena","family":"\u0141uczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mazur-Melewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.03.002_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/children4060048","article-title":"Pediatric non-alcoholic fatty liver disease","volume":"4","author":"Bush","year":"2017","journal-title":"Children"},{"key":"10.1016\/j.jceh.2021.03.002_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2021.03.002_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.002_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jceh.2021.03.002_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10238-012-0227-0","article-title":"Adiponectin: a key playmaker adipocytokine in nonalcoholic fatty liver disease","volume":"14","author":"Gatselis","year":"2014","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jceh.2021.03.002_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jceh.2021.03.002_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/BJ20102148","article-title":"Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis","volume":"440","author":"Handy","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.jceh.2021.03.002_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-10-1195","article-title":"FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women","volume":"164","author":"Terra","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jceh.2021.03.002_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ncomms14147","article-title":"A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes","volume":"8","author":"Shu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2021.03.002_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Nonalcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jceh.2021.03.002_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00042737-200107000-00004","article-title":"Cytokines in the liver","volume":"13","author":"Ramadori","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.03.002_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of nonalcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2021.03.002_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.metabol.2017.04.003","article-title":"Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic\/histological parameters in various liver diseases","volume":"72","author":"Ballestri","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2021.03.002_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fped.2018.00416","article-title":"Novel ultrasonographic fatty liver indicator can predict hepatitis in children with non-alcoholic fatty liver disease","volume":"6","author":"Liu","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jceh.2021.03.002_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","article-title":"Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD","volume":"32","author":"Ballestri","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.03.002_bib16","series-title":"Obesity and Overweight","year":"2018"},{"key":"10.1016\/j.jceh.2021.03.002_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2021.03.002_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MPG.0b013e31818fc63b","article-title":"Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network","volume":"49","author":"England","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2021.03.002_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jceh.2021.03.002_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104558","article-title":"The development of pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease","volume":"9","author":"Alkhouri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2021.03.002_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/ijms17050631","article-title":"Label-free quantitative proteomics reveals differences in molecular mechanism of atherosclerosis related and non-related to chronic kidney disease","volume":"17","author":"Luczak","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2021.03.002_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualised p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jceh.2021.03.002_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"60","author":"Polyzos","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2021.03.002_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang","year":"2018","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jceh.2021.03.002_bib25","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ijms18081649","article-title":"Adipokines and nonalcoholic fatty liver disease: multiple interactions","volume":"18","author":"Adolph","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2021.03.002_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/S0004-27302009000200012","article-title":"Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications","volume":"53","author":"Wang","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jceh.2021.03.002_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.002_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1463-1326.2009.01176.x","article-title":"The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jceh.2021.03.002_bib29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2017.01.053","article-title":"Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support","volume":"153","author":"Hoefer","year":"2017","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jceh.2021.03.002_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2253-14-67","article-title":"The role of plasma gelsolin in cardiopulmonary bypass induced acute lung injury in infants and young children: a pilot study","volume":"14","author":"Shi","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jceh.2021.03.002_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jnutbio.2010.02.007","article-title":"Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects","volume":"22","author":"Kim","year":"2011","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.jceh.2021.03.002_bib32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/00365521.2013.836754","article-title":"Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease","volume":"49","author":"Suh","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.03.002_bib33","first-page":"OC17","article-title":"The importance of liver-fatty acid binding protein in diagnosis of liver damage in patients with acute hepatitis","volume":"11","author":"Cakir","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.jceh.2021.03.002_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.alcohol.2014.09.033","article-title":"The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomised controlled trial","volume":"49","author":"de Jong","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.jceh.2021.03.002_bib35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jceh.2021.03.002_bib36","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1210\/jc.2012-1221","article-title":"Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis","volume":"97","author":"Reinehr","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.03.002_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2021.03.002_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41598-017-16312-6","article-title":"Diverse changes of circulating fibroblast growth factor 21 levels in hepatitis B virus-related diseases","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2021.03.002_bib39","first-page":"105","article-title":"Plasma gelsolin protein: a candidate biomarker for hepatitis b-associated liver cirrhosis identified by proteomic approach","volume":"8","author":"Marrocco","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jceh.2021.03.002_bib40","doi-asserted-by":"crossref","first-page":"41434","DOI":"10.18632\/oncotarget.5163","article-title":"LPS-induced TNF-\u03b1 factor mediates pro-inflammatory and pro-fibrogenic pattern in nonalcoholic fatty liver disease","volume":"6","author":"Ceccarelli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jceh.2021.03.002_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10753-007-9053-z","article-title":"The treatment withbantibody of TNF-reduces the inflammation, necrosis and fibrosis in the nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet","volume":"31","author":"Koca","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.jceh.2021.03.002_bib42","article-title":"Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study","volume":"10","author":"Jia","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2021.03.002_bib43","first-page":"705","article-title":"Vaspin, resistin, retinol-binding protein-4, interleukin-1\u03b1 and interleukin-6 in patients with nonalcoholic fatty liver disease","volume":"15","author":"Polyzos","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2021.03.002_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: results from the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jceh.2021.03.002_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5114\/ceh.2020.99515","article-title":"Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease","volume":"6","author":"Ma\u0142ecki","year":"2020","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.03.002_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14789450.2020.1810020","article-title":"Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study","volume":"17","author":"Ma\u0142ecki","year":"2020","journal-title":"Expert Rev Proteomics"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:19Z","timestamp":1760853979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0973688321000542"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.03.002","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}